» Articles » PMID: 23786652

Exploiting Paracrine Mechanisms of Tissue Regeneration to Repair Damaged Organs

Overview
Journal Transplant Res
Publisher Biomed Central
Specialty General Surgery
Date 2013 Jun 22
PMID 23786652
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Stem cells have been studied for many years for their potential to repair damaged organs in the human body. Although many different mechanisms have been suggested as to how stem cells may initiate and facilitate repair processes, much remains unknown. Recently, there has been considerable interest in the idea that stem cells may exert their effects in vivo via paracrine actions. This could involve the release of cytokines, growth factors or secreted extracellular vesicles. This article reviews the role that paracrine actions may play in tissue regeneration. In particular, it considers how microvesicles, as a mediator or modulator of paracrine action, can be exploited as a tool for non-cell-based therapies in regenerative medicine.

Citing Articles

Mesenchymal stem cells and mesenchymal stem cell-derived exosomes: a promising strategy for treating retinal degenerative diseases.

An W, Zhang W, Qi J, Xu W, Long Y, Qin H Mol Med. 2025; 31(1):75.

PMID: 39984849 PMC: 11846226. DOI: 10.1186/s10020-025-01120-w.


Maternal and neonatal factors' effects on wharton's jelly mesenchymal stem cell yield.

Mahmoud R, Bassiouny M, Badawy A, Darwish A, Yahia S, El-Tantawy N Sci Rep. 2024; 14(1):24376.

PMID: 39420012 PMC: 11487262. DOI: 10.1038/s41598-024-72386-z.


Exosomes from Human iPSC-Derived Retinal Organoids Enhance Corneal Epithelial Wound Healing.

Lee S, Han J, Yang J, Lyu J, Park H, Bang J Int J Mol Sci. 2024; 25(16).

PMID: 39201611 PMC: 11354741. DOI: 10.3390/ijms25168925.


Mesenchymal stem cells in craniofacial reconstruction: a comprehensive review.

Zheng Z, Liu H, Liu S, Luo E, Liu X Front Mol Biosci. 2024; 11:1362338.

PMID: 38690295 PMC: 11058977. DOI: 10.3389/fmolb.2024.1362338.


The Long Journey of Extracellular Vesicles towards Global Scientific Acclamation.

Pirisinu M Adv Pharm Bull. 2023; 13(3):489-501.

PMID: 37646064 PMC: 10460810. DOI: 10.34172/apb.2023.049.


References
1.
Stevenson K, Chen D, MacIntyre A, McGlynn L, Montague P, Charif R . Pancreatic-derived pathfinder cells enable regeneration of critically damaged adult pancreatic tissue and completely reverse streptozotocin-induced diabetes. Rejuvenation Res. 2011; 14(2):163-71. DOI: 10.1089/rej.2010.1099. View

2.
Nygren J, Jovinge S, Breitbach M, Sawen P, Roll W, Hescheler J . Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med. 2004; 10(5):494-501. DOI: 10.1038/nm1040. View

3.
Luan Y, Zhang X, Kong F, Cheng G, Qi T, Zhang Z . Mesenchymal stem cell prevention of vascular remodeling in high flow-induced pulmonary hypertension through a paracrine mechanism. Int Immunopharmacol. 2012; 14(4):432-7. DOI: 10.1016/j.intimp.2012.08.001. View

4.
Stevenson K, McGlynn L, Hodge M, McLinden H, George W, Davies R . Isolation, characterization, and differentiation of thy1.1-sorted pancreatic adult progenitor cell populations. Stem Cells Dev. 2009; 18(10):1389-98. DOI: 10.1089/scd.2008.0301. View

5.
Ferrari G, Coletta M, Paolucci E, Stornaiuolo A, Cossu G, Mavilio F . Muscle regeneration by bone marrow-derived myogenic progenitors. Science. 1998; 279(5356):1528-30. DOI: 10.1126/science.279.5356.1528. View